ANGITIA

Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Apr 2023)

What this means for you

This application is over — abandoned 24 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90681693
Mark type
Design + words
Filed
29 Apr 2021
Published for opposition
26 Jul 2022
Abandoned
24 Apr 2023
Attorney of record
Jinggao LI

Goods and services

  • Class 005 — Pharmaceuticals: Allergy tablets; Anti-inflammatory ointments; Anti-itch ointment; Antibiotic ointments; Antibiotic tablets; Biological tissue grafts; Bone cement for medical purposes; Bone cement for surgical and orthopaedic purposes; Bone growth media consisting of biological materials for medical purposes; Cement for bones for medical use; Ceramic materials for dental use for fillings; Drug delivery agents in the form of injections solutions that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of ointment suspensions that facilitate the delivery of pharmaceutical preparations; Hemorrhoidal ointments; Materials for dental fillings; Materials for dental fillings and for sealing purposes; Medical dressings; Medicated ointments for treating dermatological conditions; Medicated sunburn ointments; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Mentholated ointment for medical use; Mercurial ointments for medical use; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganisms for medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Skin grafts; Synthetic materials for dental use for fillings; Thyroid and para-thyroid hormone preparations; Tumor suppressing agents; Vascular grafts; Veterinary pharmaceutical preparations for the prevention of cardiovascular disorders, immune disorders, infection, nervous system disorders; Veterinary pharmaceutical preparations for the treatment of cardiovascular disorders, immune disorders, infection, nervous system disorders, anxiety disorders, cancer; Veterinary preparations, namely, pain relief medication; Vitamin D preparations

Owner

Prosecution history

  • 24 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 24 Apr 2023 — ABANDONMENT - NO USE STATEMENT FILED
  • 20 Sept 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 26 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 26 Jul 2022 — PUBLISHED FOR OPPOSITION
  • 06 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 21 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 20 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 20 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 20 Jun 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 06 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 06 Jan 2022 — NON-FINAL ACTION E-MAILED
  • 06 Jan 2022 — NON-FINAL ACTION WRITTEN
  • 28 Dec 2021 — ASSIGNED TO EXAMINER
  • 10 Sept 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED

View this trademark record on Marksy